Chemed (CHE) Operating Leases (2019 - 2026)

Chemed (CHE) has reported Operating Leases for 8 consecutive years, with $104.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Leases rose 2.32% year-over-year to $104.4 million; the TTM figure through Mar 2026 stood at $104.4 million (up 2.32% YoY), while the FY2025 annual figure was $102.9 million, up 4.39% from the prior year.
• Operating Leases came in at $104.4 million for Q1 2026 at Chemed, up from $102.9 million in the prior quarter.
• The five-year high for Operating Leases was $110.5 million in Q4 2022, with the low at $98.5 million in Q4 2024.
• Average Operating Leases over 5 years is $103.8 million, with a median of $103.4 million recorded in 2022.
• Across the five-year window, Operating Leases rose 10.43% in 2022 and declined 8.81% in 2023, its largest moves.
• Year by year, Operating Leases stood at $110.5 million in 2022, then dropped by 8.81% to $100.8 million in 2023, then fell by 2.22% to $98.5 million in 2024, then grew by 4.39% to $102.9 million in 2025, then rose by 1.54% to $104.4 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $104.4 million, $102.9 million, and $99.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.